#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Wendy Komac Email
CEO . Bryleos
Johnson City, TN
LocationPrimary Email
How to contact Wendy Komac
Join and see Wendy's contact info for free!Phone
Current Roles
Employees:
6Revenue:
$465kAbout
Early clinical stage therapeutics company developing BNAD101, a patent-pending oral composition of NAD+ clinically proven to increase intracellular NAD+. BNAD101 is a potential high-value medicine to treat challenging and costly neurological disorders. \n\nIn 2022, the Company completed its double-blind, placebo-controlled proof of concept study at the Institute of Systems Biology. The study of 60 healthy adults demonstrated BNAD101 had a 52% increase in intracellular NAD levels against placebo within just 5 days, effectively validating the potential of BNAD101 in treating not only chronic neurological conditions but conditions were swift response is critical.\n\nBryleos: More Life While LivingBryleos Address
207 North Boone StreetJohnson City, TN